These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15556002)

  • 1. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils.
    Li J; Zhu M; Rajamani S; Uversky VN; Fink AL
    Chem Biol; 2004 Nov; 11(11):1513-21. PubMed ID: 15556002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting alpha-synuclein in Parkinson's disease.
    Kapurniotu A
    Chem Biol; 2004 Nov; 11(11):1476-8. PubMed ID: 15555995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein.
    Hokenson MJ; Uversky VN; Goers J; Yamin G; Munishkina LA; Fink AL
    Biochemistry; 2004 Apr; 43(15):4621-33. PubMed ID: 15078109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nitration on the structure and aggregation of alpha-synuclein.
    Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
    Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer.
    Xu J; Wei C; Xu C; Bennett MC; Zhang G; Li F; Tao E
    Brain Res; 2007 Mar; 1139():220-5. PubMed ID: 17280646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forcing nonamyloidogenic beta-synuclein to fibrillate.
    Yamin G; Munishkina LA; Karymov MA; Lyubchenko YL; Uversky VN; Fink AL
    Biochemistry; 2005 Jun; 44(25):9096-107. PubMed ID: 15966733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metals on herbicides-alpha-synuclein association: a possible factor in neurodegenerative disease studied by capillary electrophoresis.
    André C; Truong TT; Robert JF; Guillaume YC
    Electrophoresis; 2005 Sep; 26(17):3256-64. PubMed ID: 16143978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
    Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
    Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease.
    Park JY; Lansbury PT
    Biochemistry; 2003 Apr; 42(13):3696-700. PubMed ID: 12667059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation.
    Munishkina LA; Henriques J; Uversky VN; Fink AL
    Biochemistry; 2004 Mar; 43(11):3289-300. PubMed ID: 15023080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils.
    Zhu M; Rajamani S; Kaylor J; Han S; Zhou F; Fink AL
    J Biol Chem; 2004 Jun; 279(26):26846-57. PubMed ID: 15096521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The aggregation and fibrillation of alpha-synuclein.
    Fink AL
    Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PA700, the regulatory complex of the 26S proteasome, interferes with alpha-synuclein assembly.
    Ghee M; Melki R; Michot N; Mallet J
    FEBS J; 2005 Aug; 272(16):4023-33. PubMed ID: 16098186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue.
    Bodles AM; El-Agnaf OM; Greer B; Guthrie DJ; Irvine GB
    Neurosci Lett; 2004 Apr; 359(1-2):89-93. PubMed ID: 15050719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine oxidation, alpha-synuclein and Parkinson's disease.
    Glaser CB; Yamin G; Uversky VN; Fink AL
    Biochim Biophys Acta; 2005 Jan; 1703(2):157-69. PubMed ID: 15680224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of macromolecular crowding on protein aggregation and amyloid fibril formation.
    Munishkina LA; Cooper EM; Uversky VN; Fink AL
    J Mol Recognit; 2004; 17(5):456-64. PubMed ID: 15362105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural evidence for alpha-synuclein fibrils using in situ atomic force microscopy.
    Zhang F; Ji LN; Tang L; Hu J; Hu HY; Xu HJ; He JH
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):113-8. PubMed ID: 15685368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-stranded DNA stimulates the fibrillation of alpha-synuclein in vitro and is associated with the mature fibrils: an electron microscopy study.
    Cherny D; Hoyer W; Subramaniam V; Jovin TM
    J Mol Biol; 2004 Dec; 344(4):929-38. PubMed ID: 15544803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.